Related references
Note: Only part of the references are listed.Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis
Hanna Nebenzahl-Guimaraes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Pyrosequencing for Rapid Detection of Extensively Drug-Resistant Mycobacterium tuberculosis in Clinical Isolates and Clinical Specimens
S. -Y. Grace Lin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment
Jennifer Ho et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Diagnostic Accuracy and Reproducibility of WHO-Endorsed Phenotypic Drug Susceptibility Testing Methods for First-Line and Second-Line Antituberculosis Drugs
David J. Horne et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard
Armand Van Deun et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations
Leen Rigouts et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis
Kristian Angeby et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2012)
Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis
D. A. Williamson et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system
Fernanda Maruri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region
Marina B. Gikalo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Detection of First- and Second-Line Drug Resistance in Mycobacterium tuberculosis Clinical Isolates by Pyrosequencing
Anna Engstrom et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review
Sophia B. Georghiou et al.
PLoS One (2012)
The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
Gesine Meyer-Rath et al.
PLOS ONE (2012)
Retrieval of Mycobacterium tuberculosis cultures suspended in phosphate buffered saline
V. N. Azger Dusthackeer et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2012)
Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing
David Laurenzo et al.
ACTA TROPICA (2011)
Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis
Patricia J. Campbell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge
J. van Ingen et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis
Anna Engstrom et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Pyrosequencing for Rapid Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Strains and Clinical Specimens
N. Garcia-Sierra et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis
Ashwin S. Dharmadhikari et al.
TUBERCULOSIS (2011)
GeneXpert-A Game-Changer for Tuberculosis Control?
Carlton A. Evans
PLOS MEDICINE (2011)
Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa
N. Sarita Shah et al.
EMERGING INFECTIOUS DISEASES (2011)
Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections
P. Jureen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Isioniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: Catalase, peroxidase, and INH-NADH adduct formation activities
Christine E. Cade et al.
PROTEIN SCIENCE (2010)
Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing
Havard Valvatne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results
A. Van Deun et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Tuberculosis Drug Resistance Mutation Database
Andreas Sandgren et al.
PLOS MEDICINE (2009)
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
D. I. Ling et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
The Infectiousness of Tuberculosis Patients Coinfected with HIV
A. Roderick Escombe et al.
PLOS MEDICINE (2008)